创金合信医药优选3个月持有混合C(015571)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-19,193,808.70 |
-20,316,916.84 |
-24,268,788.64 |
-13,456,645.30 |
| 利息合计 |
14,494.77 |
8,696.88 |
38,423.74 |
24,743.24 |
| 其中：存款利息收入 |
14,494.77 |
8,696.88 |
38,423.74 |
24,743.24 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-24,393,394.27 |
-16,218,195.22 |
-22,648,819.22 |
-7,409,165.31 |
| 其中：股票投资收益 |
-25,203,876.57 |
-16,882,012.02 |
-24,199,541.87 |
-8,633,348.36 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
304,765.06 |
70.45 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
810,482.30 |
663,816.80 |
1,245,957.59 |
1,224,112.60 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
5,181,998.87 |
-4,110,250.33 |
-1,806,175.27 |
-6,217,744.78 |
| 其他收入 |
3,091.93 |
2,831.83 |
147,782.11 |
145,521.55 |
| 费用 |
1,537,960.17 |
876,736.71 |
2,955,199.82 |
1,743,059.70 |
| 管理人报酬 |
1,175,638.37 |
640,394.09 |
2,304,677.28 |
1,387,666.24 |
| 基金托管费 |
195,939.70 |
106,732.39 |
325,883.91 |
185,022.14 |
| 销售服务费 |
73,835.50 |
43,661.02 |
150,221.43 |
83,131.40 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
92,546.60 |
85,949.21 |
174,416.86 |
87,239.67 |
| 利润总额 |
-20,731,768.87 |
-21,193,653.55 |
-27,223,988.46 |
-15,199,705.00 |
微信公众号
证券之星APP
基本资料
